# | Title | Journal | Year | Citations |
---|
1 | Altruism, happiness, and health: it’s good to be good | International Journal of Behavioral Medicine | 2005 | 528 |
2 | Genetic counseling and testing for Alzheimer disease: Joint practice guidelines of the American College of Medical Genetics and the National Society of Genetic Counselors | Genetics in Medicine | 2011 | 297 |
3 | Cancer communication patterns and the influence of patient characteristics: Disparities in information-giving and affective behaviors | Patient Education and Counseling | 2006 | 296 |
4 | Measurement and correlates of family caregiver self-efficacy for managing dementia | Aging and Mental Health | 2002 | 175 |
5 | Death and organ procurement: public beliefs and attitudes | Social Science and Medicine | 2004 | 150 |
6 | Rethinking organoid technology through bioengineering | Nature Materials | 2021 | 150 |
7 | Community-based participatory research (CBPR) in South Africa: Engaging multiple constituents to shape the research question | Social Science and Medicine | 2005 | 133 |
8 | Manufacturing Desire: | Social Studies of Science | 2004 | 132 |
9 | The bioethics of stem cell research and therapy | Journal of Clinical Investigation | 2010 | 131 |
10 | Predictors of patient satisfaction with inpatient hospital nursing care | Research in Nursing and Health | 2004 | 130 |
11 | Accounting for Culture in a Globalized Bioethics | Journal of Law, Medicine and Ethics | 2004 | 120 |
12 | Will Mothers Discuss Parenting Stress and Depressive Symptoms With Their Child's Pediatrician? | Pediatrics | 2004 | 117 |
13 | A communication model of shared decision making: Accounting for cancer treatment decisions. | Health Psychology | 2005 | 114 |
14 | Personal genomics and individual identities: motivations and moral imperatives of early users | New Genetics and Society | 2010 | 101 |
15 | Decision-making process for conditions nominated to the Recommended Uniform Screening Panel: statement of the US Department of Health and Human Services Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children | Genetics in Medicine | 2014 | 98 |
16 | Withdrawing Implantable Defibrillator Shock Therapy in Terminally Ill Patients | American Journal of Medicine | 2006 | 95 |
17 | Decreased Use of Adjuvant Breast Cancer Therapy in a Randomized Controlled Trial of a Decision Aid with Individualized Risk Information | Medical Decision Making | 2005 | 94 |
18 | Comparison of black and white families’ experiences and perceptions regarding organ donation requests | Critical Care Medicine | 2003 | 93 |
19 | Looking back: egg donors' retrospective evaluations of their motivations, expectations, and experiences during their first donation cycle | Fertility and Sterility | 2010 | 90 |
20 | Taking values seriously: Ethical challenges in organ donation and transplantation for critical care professionals | Critical Care Medicine | 2007 | 87 |
21 | New Advances in iPS Cell Research Do Not Obviate the Need for Human Embryonic Stem Cells | Cell Stem Cell | 2007 | 87 |
22 | Community engagement strategies for genomic studies in Africa: a review of the literature | BMC Medical Ethics | 2015 | 87 |
23 | Quality AttestationforClinical Ethics Consultants:A Two-Step Model from the American Society for Bioethics and Humanities | Hastings Center Report | 2013 | 86 |
24 | A survey of language barriers from the perspective of pediatric oncologists, interpreters, and parents | Pediatric Blood and Cancer | 2006 | 85 |
25 | Can genomics tell me who I am? Essentialistic rhetoric in direct-to-consumer DNA testing | New Genetics and Society | 2009 | 80 |
26 | State Laws Regarding the Retention and Use of Residual Newborn Screening Blood Samples | Pediatrics | 2011 | 79 |
27 | Informed Consent in International Health Research | Journal of Empirical Research on Human Research Ethics | 2006 | 78 |
28 | Genomic newborn screening: public health policy considerations and recommendations | BMC Medical Genomics | 2017 | 78 |
29 | The Reasons Families Donate Organs for Transplantation: Implications for Policy and Practice | Journal of Trauma | 2007 | 75 |
30 | Parents’ interest in whole-genome sequencing of newborns | Genetics in Medicine | 2014 | 73 |
31 | iPS Cells: Mapping the Policy Issues | Cell | 2009 | 68 |
32 | Pediatric Biobanks: Approaching Informed Consent for Continuing Research After Children Grow Up | Journal of Pediatrics | 2009 | 63 |
33 | Tailoring the process of informed consent in genetic and genomic research | Genome Medicine | 2010 | 61 |
34 | Ethics and palliative care consultation in the intensive care unit | Critical Care Clinics | 2004 | 60 |
35 | IRB perspectives on the return of individual results from genomic research | Genetics in Medicine | 2012 | 55 |
36 | Origin Myths in Bioethics: Constructing Sources, Motives and Reason in Bioethic(s) | Culture, Medicine and Psychiatry | 2008 | 54 |
37 | After the revolution? Ethical and social challenges in ‘personalized genomic medicine’ | Personalized Medicine | 2012 | 50 |
38 | Including all voices in international data-sharing governance | Human Genomics | 2018 | 50 |
39 | Measuring discord in treatment decision-making; progress toward development of a cancer communication and decision-making assessment tool | Psycho-Oncology | 2006 | 47 |
40 | Revisiting the Warnock rule | Nature Biotechnology | 2017 | 47 |
41 | Anti-aging science: The emergence, maintenance, and enhancement of a discipline | Journal of Aging Studies | 2008 | 41 |
42 | A question of ethics: Selling autologous stem cell therapies flaunts professional standards | Stem Cell Research | 2014 | 41 |
43 | AGING: Enhanced: Antiaging Research and the Need for Public Dialogue | Science | 2003 | 40 |
44 | Bioidentical hormones, menopausal women, and the lure of the “natural” in U.S. anti-aging medicine | Social Science and Medicine | 2015 | 40 |
45 | Can Focusing on Self-Care Reduce Disparities in Kidney Transplantation Outcomes? | American Journal of Kidney Diseases | 2005 | 39 |
46 | Paediatricians? attitudes about discussing maternal depression during a paediatric primary care visit | Child: Care, Health and Development | 2007 | 39 |
47 | Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? | Circulation: Arrhythmia and Electrophysiology | 2009 | 39 |
48 | ELSI 2.0 for Genomics and Society | Science | 2012 | 39 |
49 | Evaluating Harms in the Assessment of Net Benefit: A Framework for Newborn Screening Condition Review | Maternal and Child Health Journal | 2016 | 38 |
50 | The Choking Game: Physician Perspectives | Pediatrics | 2010 | 36 |